K

Kora Saude Participacoes SA
BOVESPA:KRSA3

Watchlist Manager
Kora Saude Participacoes SA
BOVESPA:KRSA3
Watchlist
Price: 8.13 BRL -1.09% Market Closed
Market Cap: 628.7m BRL
Have any thoughts about
Kora Saude Participacoes SA?
Write Note

Intrinsic Value

The intrinsic value of one KRSA3 stock under the Base Case scenario is 52.73 BRL. Compared to the current market price of 8.13 BRL, Kora Saude Participacoes SA is Undervalued by 85%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRSA3 Intrinsic Value
52.73 BRL
Undervaluation 85%
Intrinsic Value
Price
K
Base Case Scenario

Valuation History
Kora Saude Participacoes SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
KRSA3
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for KRSA3 cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about KRSA3?
Bearish
Neutral
Bullish

Fundamental Analysis

8.13 BRL
-1.09%
-1.09%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Kora Saude Participacoes SA
BR
Health Care
Market Cap
625.2m BRL
IPO
Aug 13, 2021
Employees
4 500
Brazil
Market Cap
625.2m BRL
Industry
Health Care
IPO
Aug 13, 2021
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Kora Saude Participacoes SA

Provide an overview of the primary business activities
of Kora Saude Participacoes SA.

What unique competitive advantages
does Kora Saude Participacoes SA hold over its rivals?

What risks and challenges
does Kora Saude Participacoes SA face in the near future?

Summarize the latest earnings call
of Kora Saude Participacoes SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kora Saude Participacoes SA.

Provide P/S
for Kora Saude Participacoes SA.

Provide P/E
for Kora Saude Participacoes SA.

Provide P/OCF
for Kora Saude Participacoes SA.

Provide P/FCFE
for Kora Saude Participacoes SA.

Provide P/B
for Kora Saude Participacoes SA.

Provide EV/S
for Kora Saude Participacoes SA.

Provide EV/GP
for Kora Saude Participacoes SA.

Provide EV/EBITDA
for Kora Saude Participacoes SA.

Provide EV/EBIT
for Kora Saude Participacoes SA.

Provide EV/OCF
for Kora Saude Participacoes SA.

Provide EV/FCFF
for Kora Saude Participacoes SA.

Provide EV/IC
for Kora Saude Participacoes SA.

Show me price targets
for Kora Saude Participacoes SA made by professional analysts.

What are the Revenue projections
for Kora Saude Participacoes SA?

How accurate were the past Revenue estimates
for Kora Saude Participacoes SA?

What are the Net Income projections
for Kora Saude Participacoes SA?

How accurate were the past Net Income estimates
for Kora Saude Participacoes SA?

What are the EPS projections
for Kora Saude Participacoes SA?

How accurate were the past EPS estimates
for Kora Saude Participacoes SA?

What are the EBIT projections
for Kora Saude Participacoes SA?

How accurate were the past EBIT estimates
for Kora Saude Participacoes SA?

Compare the revenue forecasts
for Kora Saude Participacoes SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kora Saude Participacoes SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kora Saude Participacoes SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kora Saude Participacoes SA compared to its peers.

Compare the P/E ratios
of Kora Saude Participacoes SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Kora Saude Participacoes SA with its peers.

Analyze the financial leverage
of Kora Saude Participacoes SA compared to its main competitors.

Show all profitability ratios
for Kora Saude Participacoes SA.

Provide ROE
for Kora Saude Participacoes SA.

Provide ROA
for Kora Saude Participacoes SA.

Provide ROIC
for Kora Saude Participacoes SA.

Provide ROCE
for Kora Saude Participacoes SA.

Provide Gross Margin
for Kora Saude Participacoes SA.

Provide Operating Margin
for Kora Saude Participacoes SA.

Provide Net Margin
for Kora Saude Participacoes SA.

Provide FCF Margin
for Kora Saude Participacoes SA.

Show all solvency ratios
for Kora Saude Participacoes SA.

Provide D/E Ratio
for Kora Saude Participacoes SA.

Provide D/A Ratio
for Kora Saude Participacoes SA.

Provide Interest Coverage Ratio
for Kora Saude Participacoes SA.

Provide Altman Z-Score Ratio
for Kora Saude Participacoes SA.

Provide Quick Ratio
for Kora Saude Participacoes SA.

Provide Current Ratio
for Kora Saude Participacoes SA.

Provide Cash Ratio
for Kora Saude Participacoes SA.

What is the historical Revenue growth
over the last 5 years for Kora Saude Participacoes SA?

What is the historical Net Income growth
over the last 5 years for Kora Saude Participacoes SA?

What is the current Free Cash Flow
of Kora Saude Participacoes SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kora Saude Participacoes SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kora Saude Participacoes SA

Current Assets 1.3B
Cash & Short-Term Investments 173.1m
Receivables 915.1m
Other Current Assets 225.4m
Non-Current Assets 3.4B
Long-Term Investments 7.1m
PP&E 1.3B
Intangibles 1.9B
Other Non-Current Assets 202m
Current Liabilities 946.7m
Accounts Payable 438.6m
Other Current Liabilities 508.2m
Non-Current Liabilities 2.9B
Long-Term Debt 2.3B
Other Non-Current Liabilities 510.4m
Efficiency

Earnings Waterfall
Kora Saude Participacoes SA

Revenue
2.8B BRL
Cost of Revenue
-2.3B BRL
Gross Profit
577.5m BRL
Operating Expenses
-208.1m BRL
Operating Income
369.4m BRL
Other Expenses
-488.8m BRL
Net Income
-119.4m BRL

Free Cash Flow Analysis
Kora Saude Participacoes SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KRSA3 Profitability Score
Profitability Due Diligence

Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
42/100
Profitability
Score

Kora Saude Participacoes SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

KRSA3 Solvency Score
Solvency Due Diligence

Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
High D/E
Low Altman Z-Score
25/100
Solvency
Score

Kora Saude Participacoes SA's solvency score is 25/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRSA3 Price Targets Summary
Kora Saude Participacoes SA

Wall Street analysts forecast KRSA3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRSA3 is 9.04 BRL with a low forecast of 5.05 BRL and a high forecast of 13.36 BRL.

Lowest
Price Target
5.05 BRL
38% Downside
Average
Price Target
9.04 BRL
11% Upside
Highest
Price Target
13.36 BRL
64% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KRSA3?

Click here to dive deeper.

Dividends

Kora Saude Participacoes SA
does not pay dividends
Shareholder Yield

Current shareholder yield for KRSA3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one KRSA3 stock?

The intrinsic value of one KRSA3 stock under the Base Case scenario is 52.73 BRL.

Is KRSA3 stock undervalued or overvalued?

Compared to the current market price of 8.13 BRL, Kora Saude Participacoes SA is Undervalued by 85%.

Back to Top